Abstract |
Chikungunya virus (CHIKV) is a re-emerging vector-borne alphavirus and is transmitted to humans by Aedes mosquitoes. Despite the re-emergence of CHIKV as an epidemic threat, there is no approved effective antiviral treatment currently available for CHIKV. Herein, we report the synthesis and structure-activity relationship studies of a class of thieno[3,2-b] pyrroles and the discovery of a trisubstituted thieno[3,2-b] pyrrole 5-carboxamide 15c that exhibits potent inhibitory activity against in vitro CHIKV infection. Compound 15c displayed low micromolar activity (EC50 value of ca. 2 μM) and limited cytotoxic liability (CC50 > 100 μM) therefore furnishing a selectivity index of greater than 32. Notably, 15c not only controlled viral RNA production, but efficiently inhibited the expression of CHIKV nsP1, nsP3, capsid, and E2 proteins at a concentration as low as 2.5 μM. More importantly, 15c also demonstrated broad spectrum antiviral activity against other clinically important alphaviruses such as O'nyong-nyong virus and Sindbis virus.
|
Authors | Kuan-Chieh Ching, Yiu-Wing Kam, Andres Merits, Lisa F P Ng, Christina L L Chai |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 58
Issue 23
Pg. 9196-213
(Dec 10 2015)
ISSN: 1520-4804 [Electronic] United States |
PMID | 26540338
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiviral Agents
- Nucleic Acid Synthesis Inhibitors
- Pyrroles
- RNA, Viral
- Viral Proteins
- thienopyrrole
|
Topics |
- Antiviral Agents
(chemistry, pharmacology)
- Chikungunya Fever
(drug therapy, virology)
- Chikungunya virus
(drug effects, genetics)
- HEK293 Cells
- Humans
- Nucleic Acid Synthesis Inhibitors
(chemistry, pharmacology)
- Protein Biosynthesis
(drug effects)
- Pyrroles
(chemistry, pharmacology)
- RNA, Viral
(genetics)
- Structure-Activity Relationship
- Viral Proteins
(genetics)
|